{"id":{"repo_id":"greenwich","oai_identifier":"oai:gala.gre.ac.uk:8110"},"canonical_url":"https://search.dev.ndltd.org/etd/greenwich/oai:gala.gre.ac.uk:8110","repository":{"repo_id":"greenwich","name":"University of Greenwich","base_url":"https://gala.gre.ac.uk/cgi/oai2"},"display":{"title":"Synthesis and biological evaluation of 1,4-benzodiazepin-2-one analogues with antitrypanosomal activity","abstract":"The 1,4-benzodiazepin-2-one motif has been taken as a privileged skeleton for making antitrypanosomal agents. A library of over sixty 1,4-benzodiazepin-2-one derivatives has been synthesised employing novel synthetic routes. These derivatives were characterised spectroscopically, by mass spectrometry, and by combustion analysis. Five derivatives were characterised, in the solid state, by single crystal X-ray crystallography. Biological assays of the library of compounds against Trypanosoma brucei brucei (T. b brucei) revealed a range of trypanocidal activities. A first generation library activity showed biological activity as low as 6.25 μM (minimum inhibitory concentration, MIC value). Structure activity relationships in this work revealed that an aromatic substituent at the C3 and N1 positions of the 1,4-benzodiazepin-2-one are important for improved bioactivity. In order to improve biological activity, putative P-2 transporter motifs were exploited in the 1,4-benzodiazepin-2-ones. Structural activity relationships indicate that the inclusion of a guanidine moiety, a putative P-2 transporter motif, can improve the biological activity of these molecules. In vitro screening of these compounds showed a range of antitrypanosomal activities against T. b.brucei, with a number in the low micromolar range (MIC ≥ 0.78 μm) including (S)-1-(4-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(3-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(4-((3-benzyl-5-cyclohexyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-1yl)methyl)phenyl)-guanidine and (S)-1-(1-benzyl-5-cyclohexyl-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-7-yl)guanidine)phenylquanidine.","abstract_html":"The 1,4-benzodiazepin-2-one motif has been taken as a privileged skeleton for making antitrypanosomal agents. A library of over sixty 1,4-benzodiazepin-2-one derivatives has been synthesised employing novel synthetic routes. These derivatives were characterised spectroscopically, by mass spectrometry, and by combustion analysis. Five derivatives were characterised, in the solid state, by single crystal X-ray crystallography. Biological assays of the library of compounds against Trypanosoma brucei brucei (T. b brucei) revealed a range of trypanocidal activities. A first generation library activity showed biological activity as low as 6.25 μM (minimum inhibitory concentration, MIC value). Structure activity relationships in this work revealed that an aromatic substituent at the C3 and N1 positions of the 1,4-benzodiazepin-2-one are important for improved bioactivity. In order to improve biological activity, putative P-2 transporter motifs were exploited in the 1,4-benzodiazepin-2-ones. Structural activity relationships indicate that the inclusion of a guanidine moiety, a putative P-2 transporter motif, can improve the biological activity of these molecules. In vitro screening of these compounds showed a range of antitrypanosomal activities against T. b.brucei, with a number in the low micromolar range (MIC ≥ 0.78 μm) including (S)-1-(4-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(3-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(4-((3-benzyl-5-cyclohexyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-1yl)methyl)phenyl)-guanidine and (S)-1-(1-benzyl-5-cyclohexyl-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-7-yl)guanidine)phenylquanidine.","abstract_has_math":false,"creators":["Rathnam, Rajendra Prasad"],"institution":"University of Greenwich","degree_name":"phd","degree_level":"doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010","date_published":"2010","updated_at":"2026-07-24T02:25:42Z","subjects":["QD Chemistry","QH301 Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Rathnam, Rajendra Prasad"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2010"]},{"key":"dc:date.issued","label":"Date","values":["2010"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Science"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Greenwich"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://gala.gre.ac.uk/id/eprint/8110/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["phd"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QD Chemistry","QH301 Biology"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The 1,4-benzodiazepin-2-one motif has been taken as a privileged skeleton for making antitrypanosomal agents. A library of over sixty 1,4-benzodiazepin-2-one derivatives has been synthesised employing novel synthetic routes. These derivatives were characterised spectroscopically, by mass spectrometry, and by combustion analysis. Five derivatives were characterised, in the solid state, by single crystal X-ray crystallography. Biological assays of the library of compounds against Trypanosoma brucei brucei (T. b brucei) revealed a range of trypanocidal activities. A first generation library activity showed biological activity as low as 6.25 μM (minimum inhibitory concentration, MIC value). Structure activity relationships in this work revealed that an aromatic substituent at the C3 and N1 positions of the 1,4-benzodiazepin-2-one are important for improved bioactivity. In order to improve biological activity, putative P-2 transporter motifs were exploited in the 1,4-benzodiazepin-2-ones. Structural activity relationships indicate that the inclusion of a guanidine moiety, a putative P-2 transporter motif, can improve the biological activity of these molecules. In vitro screening of these compounds showed a range of antitrypanosomal activities against T. b.brucei, with a number in the low micromolar range (MIC ≥ 0.78 μm) including (S)-1-(4-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(3-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(4-((3-benzyl-5-cyclohexyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-1yl)methyl)phenyl)-guanidine and (S)-1-(1-benzyl-5-cyclohexyl-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-7-yl)guanidine)phenylquanidine."]},{"key":"dc:title","label":"Title","values":["Synthesis and biological evaluation of 1,4-benzodiazepin-2-one analogues with antitrypanosomal activity"]}]}],"canonical_facts":{"dc:creator":["Rathnam, Rajendra Prasad"],"dc:date":["2010"],"dc:date.issued":["2010"],"dc:description.abstract":["The 1,4-benzodiazepin-2-one motif has been taken as a privileged skeleton for making antitrypanosomal agents. A library of over sixty 1,4-benzodiazepin-2-one derivatives has been synthesised employing novel synthetic routes. These derivatives were characterised spectroscopically, by mass spectrometry, and by combustion analysis. Five derivatives were characterised, in the solid state, by single crystal X-ray crystallography. Biological assays of the library of compounds against Trypanosoma brucei brucei (T. b brucei) revealed a range of trypanocidal activities. A first generation library activity showed biological activity as low as 6.25 μM (minimum inhibitory concentration, MIC value). Structure activity relationships in this work revealed that an aromatic substituent at the C3 and N1 positions of the 1,4-benzodiazepin-2-one are important for improved bioactivity. In order to improve biological activity, putative P-2 transporter motifs were exploited in the 1,4-benzodiazepin-2-ones. Structural activity relationships indicate that the inclusion of a guanidine moiety, a putative P-2 transporter motif, can improve the biological activity of these molecules. In vitro screening of these compounds showed a range of antitrypanosomal activities against T. b.brucei, with a number in the low micromolar range (MIC ≥ 0.78 μm) including (S)-1-(4-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(3-((3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl)phenyl)guanidine, (S)-1-(4-((3-benzyl-5-cyclohexyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-1yl)methyl)phenyl)-guanidine and (S)-1-(1-benzyl-5-cyclohexyl-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-7-yl)guanidine)phenylquanidine."],"dc:publisher.department":["School of Science"],"dc:publisher.institution":["University of Greenwich"],"dc:relation.isreferencedby":["https://gala.gre.ac.uk/id/eprint/8110/"],"dc:subject":["QD Chemistry","QH301 Biology"],"dc:title":["Synthesis and biological evaluation of 1,4-benzodiazepin-2-one analogues with antitrypanosomal activity"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["phd"]},"updated_at":"2026-07-24T02:25:42Z"}